Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mikalai Katsin"'
Autor:
Mikalai Katsin, Tatsiana Shman, Alexandr Migas, Dzmitry Lutskovich, Yuliya Serada, Yauheniya Khalankova, Yuliya Kostina, Simon Dubovik
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Corticosteroid therapy is the mainstay of immune effector cell-associated neurotoxicity syndrome (ICANS) management, although its use has been associated with worse overall survival (OS) and progression-free survival (PFS) after chimeric antigen rece
Externí odkaz:
https://doaj.org/article/b7f8fc2444014cf289dc2e0e964dd88f
Autor:
Mikalai Katsin, Dmitri Dormeshkin, Alexander Meleshko, Alexandr Migas, Simon Dubovik, Natalya Konoplya
Publikováno v:
HemaSphere, Vol 7, Iss 12, p e971 (2023)
Classical Hodgkin lymphoma (cHL) is a malignancy characterized by the presence of Hodgkin and Reed-Sternberg (HRS) cells within a complex tumor microenvironment (TME). Despite advances in conventional therapies, a subset of cHL patients experience re
Externí odkaz:
https://doaj.org/article/b4f518f26566428bbd7472b5044547f5
Autor:
Dmitri Dormeshkin, Michail Shapira, Simon Dubovik, Anton Kavaleuski, Mikalai Katsin, Alexandr Migas, Alexander Meleshko, Sergei Semyonov
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The COVID−19 pandemic not only resulted in a global crisis, but also accelerated vaccine development and antibody discovery. Herein we report a synthetic humanized VHH library development pipeline for nanomolar-range affinity VHH binders to SARS-Co
Externí odkaz:
https://doaj.org/article/40f2f04ba16249e882f08c79dbeb5223
Autor:
Dmitri Dormeshkin, Mikalai Katsin, Maria Stegantseva, Sergey Golenchenko, Michail Shapira, Simon Dubovik, Dzmitry Lutskovich, Anton Kavaleuski, Alexander Meleshko
Publikováno v:
Vaccines, Vol 11, Iss 6, p 1014 (2023)
The potential of immune-evasive mutation accumulation in the SARS-CoV-2 virus has led to its rapid spread, causing over 600 million confirmed cases and more than 6.5 million confirmed deaths. The huge demand for the rapid development and deployment o
Externí odkaz:
https://doaj.org/article/d30136d6738b45a29aa6785324ce57ee
Autor:
Dmitri Dormeshkin, Michail Shapira, Simon Dubovik, Anton Kavaleuski, Mikalai Katsin, Alexandr Migas, Alexander Meleshko, Sergei Semyonov
An emerging COVID-19 pandemic resulted in a global crisis, but also accelerated vaccine development and antibody discovery. In this work, we identified a number of nanomolar-range affinity VHH binders to SARS-CoV-2 variants of concern (VoC) receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b469de65bb274d11dbcbaca55a70c9c5
https://doi.org/10.1101/2022.06.07.495065
https://doi.org/10.1101/2022.06.07.495065
Autor:
Alexander Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich, Dzmitry Lutskovich, Chuan Wang, Dmitri Dormeshkin, Natalia Savelyeva, Mikalai Katsin
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3298
We report, in brief, the results of a phase I, non-randomized study of idiotypic DNA vaccination in patients with B-cell non-Hodgkin’s lymphoma (ISRCTN31090206). The DNA sequence of lymphoma-derived immunoglobulin variable regions was used as a tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf1a70372b4ba123b5d53300eaeefad2
https://pubmed.ncbi.nlm.nih.gov/35884359
https://pubmed.ncbi.nlm.nih.gov/35884359